|
1
|
Compston A and Coles A: Multiple
sclerosis. Lancet. 372:1502–1517. 2008. View Article : Google Scholar
|
|
2
|
Kenealy SJ, Pericak-Vance MA and Haines
JL: The genetic epidemiology of multiple sclerosis. J Neuroimmunol.
143:7–12. 2003. View Article : Google Scholar
|
|
3
|
Sawcer S, Hellenthal G, Pirinen M, et al:
Genetic risk and a primary role for cell-mediated immune mechanisms
in multiple sclerosis. Nature. 476:214–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Jager PL, Jia X, Wang J, et al:
Meta-analysis of genome scans and replication identify CD6, IRF8
and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat
Genet. 41:776–782. 2009.PubMed/NCBI
|
|
5
|
Baranzini SE, Wang J, Gibson RA, et al:
Genome-wide association analysis of susceptibility and clinical
phenotype in multiple sclerosis. Hum Mol Genet. 18:767–778. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hafler DA, Compston A, Sawcer S, et al:
Risk alleles for multiple sclerosis identified by a genomewide
study. N Engl J Med. 357:851–862. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wingerchuk DM, Hogancamp WF, O’Brien PC
and Weinshenker BG: The clinical course of neuromyelitis optica
(Devic’s syndrome). Neurology. 53:1107–1114. 1999.
|
|
8
|
Wingerchuk DM, Lennon VA, Pittock SJ,
Lucchinetti CF and Weinshenker BG: Revised diagnostic criteria for
neuromyelitis optica. Neurology. 66:1485–1489. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fukazawa T, Yamasaki K, Ito H, et al: Both
the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple
sclerosis in Japanese: clinical phenotypes and gender as important
factors. Tissue Antigens. 55:199–205. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lau KK, Wong LK, Li LS, Chan YW, Li HL and
Wong V: Epidemiological study of multiple sclerosis in Hong Kong
Chinese: questionnaire survey. Hong Kong Med J. 8:77–80.
2002.PubMed/NCBI
|
|
11
|
Das A and Puvanendran K: A retrospective
review of patients with clinically definite multiple sclerosis. Ann
Acad Med Singapore. 27:204–209. 1998.PubMed/NCBI
|
|
12
|
Kim HJ, Park HY, Kim E, et al: Common
CYP7A1 promoter polymorphism associated with risk of neuromyelitis
optica. Neurobiol Dis. 37:349–355. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kroemer RT and Richards WG: Homology
modeling study of the human interleukin-7 receptor complex. Protein
Eng. 9:1135–1142. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xue HH, Bollenbacher J, Rovella V, et al:
GA binding protein regulates interleukin 7 receptor alpha-chain
gene expression in T cells. Nat Immunol. 5:1036–1044. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alcina A, Fedetz M, Ndagire D, et al: The
T244I variant of the interleukin-7 receptor-alpha gene and multiple
sclerosis. Tissue Antigens. 72:158–161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Australia and New Zealand Multiple
Sclerosis Genetics Consortium (ANZgene). Genome-wide association
study identifies new multiple sclerosis susceptibility loci on
chromosomes 12 and 20. Nat Genet. 41:824–828. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang L, Isobe N, Yoshimura S, et al:
Interleukin-7 receptor alpha gene polymorphism influences multiple
sclerosis risk in Asians. Neurology. 76:2125–2127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kurtzke JF: Rating neurologic impairment
in multiple sclerosis: an expanded disability status scale (EDSS).
Neurology. 33:1444–1452. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barrett JC, Fry B, Maller J and Daly MJ:
Haploview: analysis and visualization of LD and haplotype maps.
Bioinformatics. 21:263–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stephens M, Smith NJ and Donnelly P: A new
statistical method for haplotype reconstruction from population
data. Am J Hum Genet. 68:978–989. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weber F, Fontaine B, Cournu-Rebeix I, et
al: IL2RA and IL7RA genes confer susceptibility for multiple
sclerosis in two independent European populations. Genes Immun.
9:259–263. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rubio JP, Stankovich J, Field J, et al:
Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis
susceptibility genes in Australians. Genes Immun. 9:624–630. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Akkad DA, Hoffjan S, Petrasch-Parwez E,
Beygo J, Gold R and Epplen JT: Variation in the IL7RA and IL2RA
genes in German multiple sclerosis patients. J Autoimmun.
32:110–115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sombekke MH, van der Voort LF, Kragt JJ,
et al: Relevance of IL7R genotype and mRNA expression in Dutch
patients with multiple sclerosis. Mult Scler. 17:922–930. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
O’Doherty C, Kantarci O and Vandenbroeck
K: IL7RA polymorphisms and susceptibility to multiple sclerosis. N
Engl J Med. 358:753–754. 2008.PubMed/NCBI
|
|
26
|
Lundmark F, Duvefelt K, Iacobaeus E, et
al: Variation in interleukin 7 receptor alpha chain (IL7R)
influences risk of multiple sclerosis. Nat Genet. 39:1108–1113.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kallio SP, Jakkula E, Purcell S, et al:
Use of a genetic isolate to identify rare disease variants: C7 on
5p associated with MS. Hum Mol Genet. 18:1670–1683. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gregory SG, Schmidt S, Seth P, et al:
Interleukin 7 receptor alpha chain (IL7R) shows allelic and
functional association with multiple sclerosis. Nat Genet.
39:1083–1091. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ramagopalan SV, Anderson C, Sadovnick AD
and Ebers GC: Genomewide study of multiple sclerosis. N Engl J Med.
357:21992–200. 2007.
|
